Hormonal contraception and the risks of STI acquisition: results of a feasibility study to plan a future randomized trial

Contraception

Volumn 77, Issue 5, 2008, Pages 366-370

  Hubacher, David ^a   Raymond, Elizabeth R ^a   Beksinska, Mags ^b   Delany Moretlwe, Sinead ^b   Smit, Jenni ^b   Hylton Kong, Tina ^c   Moench, Thomas R ^d  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Caribbean HIV/AIDS Regional Training   (Jamaica)

^d REPROTECT INC   (United States)

Author keywords

DMPA; Feasibility study; Hypothetical randomized trial; IUD; STI acquisition

Indexed keywords

COPPER INTRAUTERINE DEVICE; MEDROXYPROGESTERONE ACETATE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEASIBILITY STUDY; FEMALE; GONORRHEA; HEALTH CARE PLANNING; HEALTH SURVEY; HORMONAL CONTRACEPTION; HUMAN; INFECTION RATE; INFECTION RISK; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; OBSERVATIONAL STUDY; PATIENT PARTICIPATION; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; URINALYSIS;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CONTRACEPTIVES, ORAL, HORMONAL; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; GONORRHEA; HUMANS; INTRAUTERINE DEVICES; MEDROXYPROGESTERONE; NEISSERIA GONORRHOEAE; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 41649108404     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.01.006     Document Type: Article

References (29)

1. Morrison C.S., Bright P., Wong E.L., et al. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 31 (2004) 561-567
2. Cottingham J., and Hunter D. Chlamydia trachomatis and oral contraceptive use: a quantitative review. Genitourin Med 68 (1992) 209-216
3. Louv W.C., Austin H., Perlman J., and Alexander W.J. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 160 (1989) 396-402
4. Baeten J.M., Nyange P.M., Richardson B.A., et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 185 (2001) 380-385
5. Avonts D., Sercu M., Heyerick P., Vandermeeren I., Meheus A., and Piot P. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis 17 (1990) 23-29
6. Mohllajee A.P., Curtis K.M., Martins S.L., and Peterson H.B. Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review. Contraception 73 (2006) 154-165
7. Achilles S.L., Shete P.B., Whaley K.J., Moench T.R., and Cone R.A. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis 29 (2002) 655-664
8. Kaushic C., Ashkar A.A., Reid L.A., and Rosenthal K.L. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 77 (2003) 4558-4565
9. Jacobson D.L., Peralta L., Farmer M., Graham N.M., Gaydos C., and Zenilman J. Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis 27 (2000) 313-319
10. Marx P.A., Spira A.I., Gettie A., et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 2 (1996) 1084-1089
11. Khanna K.V., Whaley K.J., Zeitlin L., et al. Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 109 (2002) 205-211
12. Goldacre M.J., Loudon N., Watt B., et al. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J 1 (1978) 748-750
13. Kuhn L., Denny L., Pollack A.E., and Wright T.C. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. Contraception 59 (1999) 363-367
14. Sonnex C. Influence of ovarian hormones on urogenital infection. Sex Transm Infect 74 (1998) 11-19
15. Trunova N., Tsai L., Tung S., et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 352 (2006) 169-177
16. Steiner M.J., and Cates Jr. W. Condoms and sexually-transmitted infections. N Engl J Med 354 (2006) 2642-2643
17. Gallo M.F., Behets F.M., Steiner M.J., et al. Validity of self-reported 'safe sex' among female sex workers in Mombasa, Kenya-PSA analysis. Int J STD AIDS 18 (2007) 33-38
18. Warner P. Concerns regarding design, analysis, and interpretation of the Morrison study on hormonal contraceptive use and acquisition of cervical infections. Sex Transm Dis 32 (2005) 644-645
19. Crosby R.A. Condom use as a dependent variable: measurement issues relevant to HIV prevention programs. AIDS Educ Prev 10 (1998) 548-557
20. Feldblum P.J., Caraway J., Bahamondes L., et al. Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment. Contraception 72 (2005) 187-191
21. von Kesseru E., Etchepareborda J.J., Wikinski R., and Beier S. Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception 61 (2000) 317-322
22. Stringer E.M., Kaseba C., Levy J., et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 197 (2007) 144.e1-144.e8
23. Halpern S.D., Metzger D.S., Berlin J.A., and Ubel P.A. Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr 27 (2001) 281-288
24. Mohllajee A.P., Curtis K.M., and Peterson H.B. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception 73 (2006) 145-153
25. Grimes D.A. Intrauterine device and upper-genital-tract infection. Lancet 356 (2000) 1013-1019
26. Molano M., Meijer C.J., Weiderpass E., et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 191 (2005) 907-916
27. McCormack W.M., Alpert S., McComb D.E., Nichols R.L., Semine D.Z., and Zinner S.H. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med 300 (1979) 123-125
28. Morre S.A., van den Brule A.J., Rozendaal L., et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 13 Suppl 2 (2002) 12-18
29. Munk C., Morre S.A., Kjaer S.K., et al. PCR-detected Chlamydia trachomatis infections from the uterine cervix of young women from the general population: prevalence and risk determinants. Sex Transm Dis 26 (1999) 325-328